Peter Supino, Managing Director at Wolfe Research, discusses Netflix's impressive quarterly performance, emphasizing its strategic pricing and advertising tiers that cater to various consumers.

Biomarin Pharmaceutical Inc (BMRN) stock saw a modest uptick, ending the day at $61.53 which represents a slight increase of $0.28 or 0.46% from the prior close of $61.25. The stock opened at $61.67 ...

Wells Fargo & Co (WFC) stock saw a modest uptick, ending the day at $77.08 which represents a slight increase of $1.13 or 1.49% from the prior close of $75.95. The stock opened at $75.98 and touched a ...

Challenges extend to other parts of AMD’s business as well. Analysts foresee a 17% sequential decline in the client segment for Q1 2025 due to weak PC demand, a 20% drop in gaming revenue, and no ...

We recently compiled a list of the 10 Best Stocks to Invest in According to Billionaire Cliff Asness. In this article, we are ...

Fintel reports that on January 17, 2025, Wolfe Research downgraded their outlook for Spotify Technology (NYSE:SPOT) from ...

Wolfe Research downgraded Spotify (SPOT) to Peer Perform from Outperform.Stay Ahead of the Market:Discover outperforming stocks and invest ...

Analysts from Wolfe Research, Goldman Sachs, and HSBC downgrade AMD, citing weak AI chip demand and rising competition. Could ...

Another analyst is casting doubt on Advanced Micro Devices Inc.'s growth potential in graphics processing units, leading to the latest downgrade of the semiconductor stock. Wolfe Research's Chris Caso ...

AMD sees a Wolfe Research downgrade as data center GPU growth lags, but its MI350 AI chip could be a game-changer.

AMD (AMD) was in focus on Thursday as investment firm Wolfe Research downgraded the semiconductor company. Read for more.

Edwards Lifesciences (EW) stock faces a downgrade at Wolfe due to concerns over its TAVR market prospects. Read more here.